307 related articles for article (PubMed ID: 28508950)
1. Malignancy as a comorbidity in rheumatic diseases: a retrospective hospital-based study.
Wang HL; Zhou YM; Zhu GZ; Yang Z; Hua BJ
Clin Rheumatol; 2018 Jan; 37(1):81-85. PubMed ID: 28508950
[TBL] [Abstract][Full Text] [Related]
2. Comparison of cancer incidence among patients with rheumatic disease: a retrospective cohort study.
Chang SH; Park JK; Lee YJ; Yang JA; Lee EY; Song YW; Lee EB
Arthritis Res Ther; 2014 Aug; 16(4):428. PubMed ID: 25163486
[TBL] [Abstract][Full Text] [Related]
3. Risk of autoimmune rheumatic diseases in patients with palindromic rheumatism: A nationwide, population-based, cohort study.
Chen HH; Chao WC; Liao TL; Lin CH; Chen DY
PLoS One; 2018; 13(7):e0201340. PubMed ID: 30048527
[TBL] [Abstract][Full Text] [Related]
4. Survival rates of cancer patients with and without rheumatic disease: a retrospective cohort analysis.
Park JK; Yang JA; Ahn EY; Chang SH; Song YW; Curtis JR; Lee EB
BMC Cancer; 2016 Jul; 16():381. PubMed ID: 27412038
[TBL] [Abstract][Full Text] [Related]
5. Comparing the burdens of opportunistic infections among patients with systemic rheumatic diseases: a nationally representative cohort study.
Hsu CY; Ko CH; Wang JL; Hsu TC; Lin CY
Arthritis Res Ther; 2019 Oct; 21(1):211. PubMed ID: 31604447
[TBL] [Abstract][Full Text] [Related]
6. Association of systemic and thyroid autoimmune diseases.
Biró E; Szekanecz Z; Czirják L; Dankó K; Kiss E; Szabó NA; Szucs G; Zeher M; Bodolay E; Szegedi G; Bakó G
Clin Rheumatol; 2006 Mar; 25(2):240-5. PubMed ID: 16247581
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary pathology of the rheumatic diseases.
Leslie KO; Trahan S; Gruden J
Semin Respir Crit Care Med; 2007 Aug; 28(4):369-78. PubMed ID: 17764055
[TBL] [Abstract][Full Text] [Related]
8. Pneumocystis jirovecii pneumonia in autoimmune rheumatic diseases: a nationwide population-based study.
Hsu HC; Chang YS; Hou TY; Chen LF; Hu LF; Lin TM; Chiou CS; Tsai KL; Lin SH; Kuo PI; Chen WS; Lin YC; Chen JH; Chang CC
Clin Rheumatol; 2021 Sep; 40(9):3755-3763. PubMed ID: 33646447
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of systemic autoimmune rheumatic diseases and clinical significance of ANA profile: data from a tertiary hospital in Shanghai, China.
Yang Z; Ren Y; Liu D; Lin F; Liang Y
APMIS; 2016 Sep; 124(9):805-11. PubMed ID: 27328803
[TBL] [Abstract][Full Text] [Related]
10. The five major autoimmune diseases increase the risk of cancer: epidemiological data from a large-scale cohort study in China.
Zhou Z; Liu H; Yang Y; Zhou J; Zhao L; Chen H; Fei Y; Zhang W; Li M; Zhao Y; Zeng X; Zhang F; Yang H; Zhang X
Cancer Commun (Lond); 2022 May; 42(5):435-446. PubMed ID: 35357093
[TBL] [Abstract][Full Text] [Related]
11. Incidence and Risk Factors of Mental Illnesses Among Patients with Systemic Autoimmune Rheumatic Diseases: An 18-year population-based study.
Chu WM; Chao WC; Chen DY; Ho WL; Chen HH
Rheumatology (Oxford); 2024 Apr; ():. PubMed ID: 38579187
[TBL] [Abstract][Full Text] [Related]
12. Idiopathic inflammatory myopathy associated with malignancy: a retrospective cohort of 151 Korean patients with dermatomyositis and polymyositis.
So MW; Koo BS; Kim YG; Lee CK; Yoo B
J Rheumatol; 2011 Nov; 38(11):2432-5. PubMed ID: 21844145
[TBL] [Abstract][Full Text] [Related]
13. Malignant neoplasms in autoimmune rheumatic diseases: examination of the risk of developing a malignancy among five different rheumatic diseases in one institution.
Villa AR; Kraus A; Jiménez-Corona A; Sandino S; Velázquez-González A; Granados J; Alarcón-Segovia D
J Clin Rheumatol; 2000 Aug; 6(4):176-83. PubMed ID: 19078467
[TBL] [Abstract][Full Text] [Related]
14. Polymyositis/dermatomyositis and malignancy risk: a metaanalysis study.
Yang Z; Lin F; Qin B; Liang Y; Zhong R
J Rheumatol; 2015 Feb; 42(2):282-91. PubMed ID: 25448790
[TBL] [Abstract][Full Text] [Related]
15. Serum soluble Fas levels in patients with autoimmune rheumatic diseases.
Sahin M; Aydintug O; Tunc SE; Tutkak H; Naziroğlu M
Clin Biochem; 2007 Jan; 40(1-2):6-10. PubMed ID: 17056024
[TBL] [Abstract][Full Text] [Related]
16. Risk of cancer in patients with dermatomyositis or polymyositis, and follow-up implications: a Scottish population-based cohort study.
Stockton D; Doherty VR; Brewster DH
Br J Cancer; 2001 Jul; 85(1):41-5. PubMed ID: 11437400
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and incidence in patients with autoimmune rheumatic diseases: a nationwide population-based study in Taiwan.
Yu KH; See LC; Kuo CF; Chou IJ; Chou MJ
Arthritis Care Res (Hoboken); 2013 Feb; 65(2):244-50. PubMed ID: 22899470
[TBL] [Abstract][Full Text] [Related]
18. High incidence of malignancies in patients with dermatomyositis and polymyositis: an 11-year analysis.
Maoz CR; Langevitz P; Livneh A; Blumstein Z; Sadeh M; Bank I; Gur H; Ehrenfeld M
Semin Arthritis Rheum; 1998 Apr; 27(5):319-24. PubMed ID: 9572713
[TBL] [Abstract][Full Text] [Related]
19. [Nation-wide survey for the treatment with cyclosporin A of interstitial pneumonia associated with collagen diseases].
Harigai M; Hara M; Kamatani N; Kashiwazaki S
Ryumachi; 1999 Dec; 39(6):819-28. PubMed ID: 10695405
[TBL] [Abstract][Full Text] [Related]
20. Cancer Risk in Patients With Inflammatory Systemic Autoimmune Rheumatic Diseases: A Nationwide Population-Based Dynamic Cohort Study in Taiwan.
Yu KH; Kuo CF; Huang LH; Huang WK; See LC
Medicine (Baltimore); 2016 May; 95(18):e3540. PubMed ID: 27149461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]